Calliditas Therapeutics AB (publ) CALT
40.00 +40.00
Day range unavailable
52-week range unavailable
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 1.21B | 802.88M | 229.35M | 874.00K | 184.83M | |
| 1.15B | 787.68M | 229.35M | 874.00K | 184.83M | |
| -373.06M | -421.94M | -524.46M | -379.72M | -28.02M | |
| -466.19M | -412.27M | -500.29M | -433.49M | -32.58M | |
| -17.38 | -15.56 | -19.68 | -19.32 | -1.76 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 973.73M | 1.25B | 955.51M | 996.30M | 753.54M | |
| 1.86B | 1.95B | 1.46B | 1.46B | 845.20M | |
| 1.52B | 1.19B | 451.63M | 207.61M | 57.13M | |
| 966.60M | 728.82M | 213.22M | 878.00K | 0 | |
| 334.81M | 766.26M | 1.01B | 1.21B | 788.07M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -434.65M | -311.35M | -461.59M | -309.18M | -71.01M | |
| -13.74M | -5.14M | -24.34M | -172.61M | -18.07M | |
| 199.65M | 575.99M | 435.16M | 768.56M | 198.84M | |
| -248.75M | 259.49M | -50.77M | 286.77M | 109.75M |